
|
Investor Relations
EnteroMedics Inc. was established in late 2002 to develop and commercialize a new therapeutic platform for treating a wide range of acute and chronic diseases that are mediated by the vagal nerves. Due to the large unmet need for more effective surgical management of obesity, and following an in-depth analysis of how the vagus nerve affects food intake and processing, EnteroMedics has selected obesity management as its primary focus. At its Saint Paul, Minnesota headquarters, EnteroMedics employs approximately 50 dedicated professionals with vast experience in basic and applied research, technology development, clinical evaluation, quality processes, regulatory submissions and business acumen. Recent Releases
Jun 30, 2009
Home | What is VBLOC® Therapy? | Why VBLOC® Therapy?
|